Differentiating Primary Tumors for Brain Metastasis with Integrated Radiomics from Multiple Imaging Modalities
Disease Markers · 26.09.2022 · 2022 · 1-8
DOI: 10.1155/2022/5147085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Markers, erschienen am 26.09.2022. Verfasst von Guoquan Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Radiology Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 325000. Hauptthemen laut MEDLINE: Brain Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wenzhou Municipal Science and Technology Bureau, Health Commission of Zhejiang Province, Science and Technology Department of Zhejiang Province.
Abstract (Originalsprache)
Objectives
To differentiate the primary site of brain metastases (BMs) is of high clinical value for the successful management of patients with BM. The purpose of this study is to investigate a combined radiomics model with computer tomography (CT) and magnetic resonance imaging (MRI) images in differentiating BMs originated from lung and breast cancer.
Methods
Pretreatment cerebral contrast enhanced CT and T1-weighted MRI images of 78 patients with 179 BMs from primary lung and breast cancer were retrospectively analyzed. Radiomic features were extracted from contoured BM lesions and selected using the Mann–Whitney U test and the least absolute shrinkage and selection operator (LASSO) logistic regression. Binary logistic regression (BLR) and support vector machine (SVM) models were built and evaluated based on selected radiomic features from CT alone, MRI alone, and combined images to differentiate BMs originated from lung and breast cancer.
Results
A total of 10 and 6 optimal radiomic features were screened out of 1288 CT and 1197 MRI features, respectively. The mean area under the curves (AUCs) of the BLR and SVM models using fivefolds cross-validation were 0.703 vs. 0.751, 0.718 vs. 0.754, and 0.781 vs. 0.803 in the training dataset and 0.708 vs. 0.763, 0.715 vs. 0.717, and 0.771 vs. 0.805 in the testing dataset for models with CT alone, MRI alone, and combined CT and MRI radiomic features, respectively.
Conclusions
Radiomics model based on combined CT and MRI features is feasible and accurate in the differentiation of the primary site of BMs from lung and breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Radiology Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 325000.
- Radiotherapy Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 325000.
- Medical and Radiation Oncology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 325000.
- School of Basic Medical Science, Wenzhou Medical University, Wenzhou, China 325000.
ORCID-Profile: Congying Xie, Xiance Jin
Förderung
- Wenzhou Municipal Science and Technology Bureau
- Health Commission of Zhejiang Province
- Science and Technology Department of Zhejiang Province
Zitieren
APA
Cao, G., Zhang, J., Lei, X., Yu, B., Ai, Y., Zhang, Z., Xie, C., & Jin, X. (2022). Differentiating Primary Tumors for Brain Metastasis with Integrated Radiomics from Multiple Imaging Modalities. Disease Markers, 2022, 1-8. https://doi.org/10.1155/2022/5147085
Vancouver
Cao G, Zhang J, Lei X, Yu B, Ai Y, Zhang Z, et al. Differentiating Primary Tumors for Brain Metastasis with Integrated Radiomics from Multiple Imaging Modalities. Disease Markers. 2022;2022:1-8. doi:10.1155/2022/5147085
BibTeX
@article{Cao2022,
author = {Cao, Guoquan and Zhang, Ji and Lei, Xiyao and Yu, Bing and Ai, Yao and Zhang, Zhenhua and Xie, Congying and Jin, Xiance},
title = {Differentiating Primary Tumors for Brain Metastasis with Integrated Radiomics from Multiple Imaging Modalities},
journal = {Disease Markers},
year = {2022},
volume = {2022},
pages = {1--8},
doi = {10.1155/2022/5147085}
}
EUVIMED